In general, the interobserver agreement for ER and PR assessment for clinical management issues has been excellent for ER-negative cases and fair or good for strongly positive cases, with the worst consistency in allocating tumours to the moderate and low level of receptor positivity [23]. Here, PGR is linked to neoplasm.